A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past

NCT00001029 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

654

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Zidovudine
DRUG: Zalcitabine
DRUG: Didanosine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]